Synthesis and structure-activity relationships of potential anticancer agents: Alkylcarbamates of 3-(9-acridinylamino)-5-hydroxymethylaniline

Journal of Medicinal Chemistry

Volumn 42, Issue 23, 1999, Pages 4741-4748

  Su, Tsann Long ^a   Chen, Ching Huang ^a   Huang, Lin Fei ^a   Chen, Chao Hao ^a   Basu, Manas K ^a   Zhang, Xiu Guo ^b   Chou, Ting Chao ^b  

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (9 ACRIDINYLAMINO) 5 HYDROXYMETHYLANILINE DERIVATIVE; 3 (9 ACRIDINYLAMINO) 5 HYDROXYMETHYLANILINE ETHYLCARBAMIC ACID; 4' METHYL 5' DIMETHYLAMINOETHYLCABOXAMIDO 3 (9 ACRIDINYLAMINO) 5 HYDROXYMETHYLANILINE ETHYLCARBAMIC ACID; AMSACRINE; ANTINEOPLASTIC AGENT; DOXORUBICIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MOUSE; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ACRIDINES; ANIMALS; ANTINEOPLASTIC AGENTS; CARBAMATES; DRUG SCREENING ASSAYS, ANTITUMOR; HL-60 CELLS; HUMANS; MALE; MICE; NEOPLASM TRANSPLANTATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032751562     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9901226     Document Type: Article

References (35)

1. Atwell, G. J.; Cain, B. F.; Seelye, R. N. Potential Antitumor Agents. 12. 9-Anilinoacridines. J. Med. Chem. 1972, 15, 611-615.
2. Cain, B. F.; Seelye, R. N.; Atwell, G. J. Potential Antitumor Agents. 14. Acridinylmethanesulfonides. J. Med. Chem. 1974, 17, 922-930.
3. Cain, B. F.; Atwell, G. J.; Denny, W. A. Potential Antitumor Agents. 16. 4′-(Acridin-9-ylamino)methanesulfonilides. J. Med. Chem. 1975, 18, 1110-1117.
4. Rewcastle, G. W.; Atwell, G. J.; Chambers, D.; Baguley, B. C.; Denny, W. A. Potential Antitumor agents. 46. Structure-Activity Relationships for Acridine Monosubstituted Derivatives of the Antitumor Agent N-[2-(dimethylamino)ethyl]-9-aminoacridine-4-carboxamide. J. Med. Chem. 1986, 29, 472-477.
5. Cain, B. F.; Atwell, G. J. The Experimental Antitumour Properties of Three Congeners of the Acridinylmethanesulfonilides (AMSA) Series. Eur. J. Cancer 1974, 10, 539-549.
6. Denny, W. A.; Atwell, G. J.; Baguley, B. C. Potential Antitumor Agents. 40. Orally Active 4,5-Disubstituted Derivatives of Amsacrine. J. Med. Chem. 1984, 27, 363-367.
7. Legha, S. S.; Gutterman, J. U.; Hall, S. W.; Benjamin, R. S.; Burgess, M. A.; Valdivieso, M.; Bodey, G. P. Phase I Clinical Investigation of 4′-(9-Acridinylamino)methanesulfon-m-anisidide (NS 249992), a New Acridine Derivative. Cancer Res. 1978, 38, 3712-3716.
8. Cabanillas, F.; Legha, S. S.; Bodey, G. P.; Freireich, E. J. Initial Experience with AMSA as Single Agent Treatment Against Malignant Lymphoproliferative Disorders. Blood 1981, 57, 614-616.
9. Arlin, Z. Current Status of Amsacrine Combination Therapy Programs in Acute Leukemia. Cancer Treat. Rep. 1983, 967-970.
10. Baguley, B. C.; Denny, W. A.; Atwell, G. J.; Finlay, G. J.; Rewcastle, G. W.; Twigden, S. J.; Wilson, W. R. Synthesis, Antitumor Activity, and DNA Binding Properties of a New Derivative of Amsacrine, N-5-Dimethylamino-9-[(2-methoxy-4-methyl sulfonylamino)phenylamino]-4-acridinecarboxamide. Cancer Res. 1984, 44, 3245-3251.
11. Denny, W. A.; Atwell, G. J.; Rewcastle, G. W.; Baguley, B. C. Potential Antitumor Agents. 49. 5-Substituted Derivatives of N-[2-(Dimethylamino)ethyl]-9-aminoacridine-4-carboxamide with in Vivo Solid Tumor Activity. J. Med. Chem. 1987, 30, 658-663.
12. Shoemaker, D. D.; Cysyk, R. L.; Gormley, P. E.; De Souza, J. J.; Malspeis, L. Metabolism of 4′-(9-Acridinylamino)methanesulfon-m-anisidide by Rat Liver Microsomes. Cancer Res. 1984, 44, 1939-1945.
13. Shoemaker, D. D.; Cysyk, R. L.; Padmanabhan, S.; Bhat, H. B.; Malspeis, L. Identification of the Principal Biliary Metabolite of 4′-(9-Acridinylamino)methanesulfon-m-anisidide in Rats. Drug Metab. Dispos. 1982, 10, 35-39.
14. Robertson, I. G.; Kestell, P.; Dormer, R. A.; Paxton, J. W. Involvement of Glutathione in the Metabolism of the Anilinoacridine Antitumor Agents CI-921 and Amsacrine. Drug Metab. Drug Interact. 1988, 6, 371-381.
15. Robertson, I. G.; Palmer, B. D.; Paxton, J. W.; Shaw, G. J. Differencess in the Metabolism of the Antitumor Agents Amsacrine and Its Derivative IC-921 in Rat and Mouse. Xenobiotica 1992, 22, 657-669.
16. Su, T.-L.; Chou, T.-C.; Kim, J. Y.; Huang, J.-T.; Ciszewska, G.; Ren, W.-Y.; Otter, G. M.; Sirotnak, F. M.; Watanabe, K. A. 9-Substituted Acridine Derivatives with Long Half-Life and Potent Antitumor Activity: Synthesis and Structure-Activity Relationships. J. Med. Chem. 1995, 38, 3226-3235.
17. Chou, T.-C.; Leteutre, F. F.; Su, T.-L.; Watanabe, K. A.; Kong, X.; Beck, W. T.; Pommier, Y. A New Class of Water-Soluble Acridinyl Derivatives that Exhibit Topo II Mediated DNA Cleavage and Antitumor Efficacy. Proc. Am. Assoc. Cancer Res. 1994, 368.
18. Scarborough, A.; Su, T.-L.; Leteutre, F. F.; Pommier, Y.; Chou, T.-C. DNA Interaction and Topoisomerase II Inhibition by the Antitumor Agent 3-(9-Acridinylamino)-5-hydroxymethylaniline and Derivatives. Bioorg. Chem. 1996, 24, 229-241.
19. Nelson, E. M.; Tewey, K. M.; Liu, L. F. Mechanism of Antitumor Drug Action: Poisoning of Mammalian DNA Topoisomerase II on DNA by 4′-(9-Acrdinylamino)methanesulfon-m-anisidide. Proc. Natl Acad. Sci. U.S.A. 1984, 81, 1361-1365.
20. Pommier, Y.; Zwelling, L. A.; Kao-Shan, C.-S.; Whang-Peng, J.; Bradley, M. O. Correlations between Intercalator-Induced DNA Strand Breaks and Sister Chromatid Exchanges, Mutations, and Cytotoxicity in Chinese Hamster Cells. Cancer Res. 1986, 45, 3143-3149.
21. Su, T.-L.; Wu, F.; Zheng, Y.-H.; Scaborough, A.; Chou, T.-C. New Acridine Carbamate Derivatives as Potent Topoisomerase II-Mediated Antitumor Agents. Proc. Am. Assoc. Cancer Res. 1996, 56, 5.
22. Wakelin, L. P.; Denny, W. A. In Molecular Basis of Specificity in Nucleic Acid-Drug Interactions; Pillman, B., Jortner, J., Kulwer, J. J., Eds.; Academic Press: Dordrecht, The Netherlands, 1990; pp 191-206.
23. Wakelin, L. P.; Chetcuti, P.; Denny, W. A. Kinetic and Equilibrium Binding Studies of Amsacrine-4-carboxamides: a Class of Asymmetrical DNA-Intercalating Agents which Bind by Threading through the DNA Helix. J. Med. Chem. 1990, 33, 2039-2044.
24. Bailly, C.; Denny, W. A.; Mellor, L. E.; Wakelin, L. P.; Waring, M. J. Sequence Specificity of the Binding of 9-Aminoacridine and Amsacrine-4-carboxamides to DNA Studies by DNAse I Foot-printing. Biochemistry 1992, 31, 3514-3524.
25. Villemey, L. The Relations between Fluorescence and the Natural of the Molecule of 9(10)-acridone. Ann. Chim. 1950, 5, 570-593.
26. Baguley, B. C.; Denny, W. A.; Atwell, G. J.; Cain, B. F. Potential Antitumor Agents. 35. Quantitative Relationships between Antitumor (L1210) Potency and DNA Binding for 4′-(9-Acridinylamino)methanesulfon-m-anisidide Analogues. J. Med. Chem. 1981, 24, 520-525.
27. Rewcastle, G. W.; Denny, W. A. The synthesis of Substituted 9-Oxoacrdin-4-carboxylic Acids; Part 2. The Use of 2-Iodoisophthalic Acid in the Jourdan-Ullmann Reaction. Synthesis 1985, 217-219.
28. Scherrer, R. A.; Beaty, H. R. Preparation of ortho-Substituted Benzoic Acids by the Copper (II)-Catalyzed Reaction of Diphenyliodonium-2-carboxylate with Anilines and other Nucleophiles. J. Org. Chem. 1980, 45, 2127-2131.
29. Brennan, S. T.; Colbry, N. L.; Leeds, R. L.; Leja, B.; Priebe, S. R.; Reily, M. D.; Showalter, H. D. H.; Uhlendorf, S. E. A Process Synthesis of the Disubstituted Amsacrine Analogue CI-921. J. Heterocycl. Chem. 1989, 26, 1469-1476.
30. MacDonald, T. L.; Lehnert, E. K.; Loper, J. T.; Chow, K.-C.; Ross, W. E. On the Mechanism of Interaction of DNA Topoisomerase II with Chemotherapeutic Agents. In DNA Topoisomerases in Cancer; Potmesel, M., Kohn, K. W., Eds.; Oxford University Press: Oxford, U.K., 1991; pp 199-214.
31. Denny, W. A.; Cain, B. F.; Atwell, G. J.; Hansch, C.; Panthananickal, A.; Leo, A. Potential Antitumor Agents. 36. Quantitative Relationships between Experimental Antitumor Activity, Toxicity, and Structure for the General Class of 9-Anilinoacridine Antitumor Agents. J. Med. Chem. 1982, 25, 276-315.
32. Scudiero, D. A.; Shoemaker, R. H.; Paull, K. D.; Monks, A.; Tierney, S.; Nofziger, T. H.; Currens, M. J.; Seniff, D.; Boyd, M. R. Evaluation of a Soluble Tetrazolium/Formazan Assay for Cell Growth and Drug Sensitivity in Culture Using Human and other Cell Lines. Cancer Res. 1988, 48, 4827-4833.
33. Chou, T.-C.; Zhang, X.-G.; Harris, C. R.; Kuduk, S. D.; Balog, A.; Savin, K.; Danishefsky, S. J. Desoxyepothilones B is Curative Against Human Tumor Xenografts that are Refractory to Paclitazel. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 9642-9647.
34. Chou, T.-C.; Hayball, M. CalcuSyn for Windows, Multiple-Drugs Dose-Effect Analyzer and Manual; Biosoft: Cambridge Place, Cambridge, U.K., 1996.
35. Chou, T.-C. The Median-Effect Principle and the Combination Index for Quantitation of Synergism and Antagonism. In Synergism and Antagonism in Chemotherapy; Chou, T.-C.,; Rideout, D. C., Eds.; Academic Press: San Diego, 1991; pp 61-102.